COVID-X bridges the gap between the European digital sector and healthcare providers. The program will unlock the full capacity of Artificial Intelligence and Data Technology solutions to overcome COVID-19 Challenges, fast-tracking projects to market and save lives.
COVID-X invites market-oriented SMEs to provide innovative products to help fight the COVID-19 pandemic.
An SME is considered eligible for COVID-X Acceleration Process if it complies will ALL the following rules:
Any selected proposer will sign a dedicated Sub-Grantee Funding Agreement with the COVID-X consortium. The funds attached to the Sub-Grantee Funding Agreement come directly from the funds of the European Project COVID-X funded itself by the Executive Agency for Small and Medium- sized Enterprises (EASME), and remain therefore, property of the EU until the payment of the balance, whose management rights have been transferred to the project partners in COVID-X via European Commission Grant Agreement Number 101016065.
Deadline to Apply: 27 January 2021